Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
about
Biological markers of Alzheimer's diseaseTherapeutic and diagnostic challenges for frontotemporal dementiaIdentification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseBiomarkers for cognitive impairment and dementia in elderly people.The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus.Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platformsCerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.Update on frontotemporal dementia.Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.Modeling the dementia epidemic.Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports.Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe.Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia.Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia.
P2860
Q26823847-D734AD73-EB4F-47A7-86C8-82C30E72A0A0Q26998919-871328DB-2A6F-489C-8312-0B3155C25C63Q28743561-46534F6C-AA1E-46BD-B639-4600DDAF79F4Q30370745-8B9175C8-90F7-4C60-B17C-DD7E8753FDEDQ34296479-A5B9341C-150E-47ED-807A-DFCD085B6B2FQ34995705-BD34A110-4D1E-4F90-A52A-F3C9E411E336Q36157458-06829E30-5138-4656-97E6-152ECAAD64B3Q36482533-1621DD61-3024-4938-98E9-21C55253F605Q36626657-66FDC906-14A7-4DA6-90A1-F6506621717CQ36784381-B1D47031-532F-493F-8F5D-675EC40F3529Q37068847-49FD470F-7961-4FD8-AB76-A146B0687E55Q37845820-657041D8-8378-4BF9-8A79-903C2C1E0331Q37954450-67F321DB-5FFB-499C-B5C7-F2DF0B459040Q38384526-C8F39433-EF4A-42B2-8E6E-37EB38621DB5Q38392505-739CD4A4-1FF7-4122-AC53-9E46D193C1E9Q38903262-B1C51960-35FB-407F-987B-A9F701B92ACEQ40777128-AE91FA2C-261C-4BE0-B45E-2C41A3896807Q42593353-F556AF68-B6CA-4DFE-9BFD-5DFD70CFA7A1Q43805520-1EE8E974-F97B-424D-9439-2D1617109333Q47893862-9A4F5FBE-DFB3-4CF5-A282-D82D9B07551DQ48036453-D01A73FA-C68E-4C40-A111-B37AB08C2341Q48824117-938A2640-6597-42BA-B937-7622C7BF5502Q53324246-18BC6DE3-399F-4D08-8C2E-7BD5BA57F9ED
P2860
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
@en
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
@nl
type
label
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
@en
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
@nl
prefLabel
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
@en
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
@nl
P2093
P1476
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.
@en
P2093
Anastasios Bonakis
Demetris Vassilopoulos
Elisabeth Kapaki
George P Paraskevas
Ioannis Zalonis
Nikolaos Kalfakis
P356
10.1097/WAD.0B013E3181610FEA
P407
P577
2008-01-01T00:00:00Z